We discover and produce innovative and reliable medicines that create a brighter future for patients in disease areas where there is great unmet medical need.
Astellas Pharma Inc. is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need. Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, marrying nearly two centuries of collective experience in producing pharmaceutical drugs. We combine the deep expertise brought by this long heritage with the forward-thinking outlook of a young company. At the heart of that outlook is the patient.
Now, Astellas employs more than 17,500 people globally and is a world leader in the development of innovative new medicines. With our ethos of CHANGING TOMORROWTM, Astellas is committed to exploring therapeutic areas in which there is a vital need for treatments that improve and lengthen patients’ lives. We’re not in the business of making ‘me too’ medicines. We strive to develop therapies that are first-in-class and best-in-class. Treatments that offer patients and their doctors genuinely new options for improving care.
Please view Astellas Global Code of Conduct here:
Please view Astellas Global Policy Summary / Position Statements here:
Japanese and regional excellence
Our global expertise makes us a dynamic innovator and reliable partner.
At our core, Astellas is committed to creating a brighter future for patients. But our commitment extends far wider. We are dedicated to working with healthcare professionals, governments, payers, business partners, employees and all our other stakeholders to meet their needs and establish positive working collaborations that make a real difference.
Being a great pharmaceutical leader needs smart thinking and a deep understanding of the industry landscape. At Astellas, we make considered, strategic decisions about all aspects of our business. We foster a high performance culture and believe that the contribution of every individual is critical to our achievement as an organisation. Our medium size helps us stay agile and connected, so that we can respond quickly to the evolving needs of the patients, doctors and healthcare systems we serve.
Innovation is the foundation on which the success of Astellas and our ethos of CHANGING TOMORROW rests. Over the last few years, we have increased our R&D capability substantially. With several major new therapies now available, and many investigational treatments in the pipeline, our focus on medical research is helping create a brighter future for patients. But, for us, innovation isn’t just about developing new medicines. Astellas is a dynamic and fast-growing business, with a strong belief in encouraging creative spirit and individuality across everything we do. We nurture new talent and value the fresh thinking each employee brings. Our European headquarters is located in a unique building designed by world-leading architect, Sir Norman Foster, to enhance creativity, connectivity, motivation and wellbeing.
Astellas knows the difference good medicines make to peoples’ lives. That‘s why we focus on providing treatments that are a genuine advance on the current standards of care – particularly in disease areas where options are limited.